University of Iowa-Holden Comprehensive Cancer Center ( Site 0115) is a clinical research site located in Iowa City, Iowa, United States 52242.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
University of Iowa-Holden Comprehensive Cancer Center ( Site 0115) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory, Primary Mediastinal Large B-cell Lymphoma Recurrent.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Iowa-Holden Comprehensive Cancer Center ( Site 0115) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Iowa-Holden Comprehensive Cancer Center ( Site 0115) has 1 clinical trials on record, with 1 currently active. Their work covers Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory, Primary Mediastinal Large B-cell Lymphoma Recurrent.
University of Iowa-Holden Comprehensive Cancer Center ( Site 0115) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.